Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New vectors for gene therapy.

M Grez1, H von Melchner

  • 1Laboratory for Molecular Virology, Georg-Speyer-Haus, Frankfurt, Germany.

Stem Cells (Dayton, Ohio)
|September 30, 2000
PubMed
Summary

New retrovirus vectors self-delete unwanted viral sequences after gene transfer into hematopoietic stem cells. This improves gene therapy safety by preventing recombination and enhancing therapeutic gene expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024
Same author

Contribution of the use of basic telemedicine tools to the care of children and adolescents with juvenile idiopathic arthritis at the Puerto Montt Hospital, Chile.

Revista chilena de pediatria·2018
Same author

Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells.

British journal of cancer·2014
Same author

Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors.

Leukemia·2014
Same author

Histone arginine methylation keeps RUNX1 target genes in an intermediate state.

Oncogene·2012
Same author

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.

Oncogene·2012

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Retrovirus vectors are efficient for gene transfer into hematopoietic stem cells.
  • Viral sequences in vectors can cause safety issues like recombination and gene silencing.

Purpose of the Study:

  • To develop a new generation of retrovirus vectors that enhance safety and efficiency for gene therapy.
  • To eliminate non-essential viral sequences post-integration.

Main Methods:

  • Developed self-deleting retrovirus vectors utilizing the Cre-loxP site-specific recombination system.
  • Vectors are designed to excise proviral sequences after integration into the host genome.

Main Results:

  • The novel vectors successfully excise non-essential viral sequences, including tRNA primer binding sites and LTRs.
  • This self-deletion mechanism prevents the generation of replication-competent retroviruses and reduces transcriptional repression.

Conclusions:

  • Self-deleting retrovirus vectors represent a significant advancement for safer gene therapy.
  • These vectors improve the expression of therapeutic genes in hematopoietic stem cells by removing inhibitory sequences.

Related Experiment Videos